eSource has long been touted as the solution to high data management and monitoring costs and inefficiencies. This talk will cover the history of eSource, why it has not taken off as quickly as people thought and where eSource is headed. From EMR/EHR, to wearables, to site source, the industry is moving towards capturing data once electronically for clinical trials and then repurposing it for downstream analysis.
eSource has the potential to change the antiquated process of capturing data during a clinical trial. The effect on the efficiency of clinical trials, monitoring, site, and data management processes will be significant. The cost of clinical data capture has increased over the years and this has got to stop. eSource can lead to lower overall costs for sites, data management and monitoring.
The life science industry has been slow to adopt eSource and it is primarily because most people do not understand or misunderstand what eSource really is and how it can benefit them. This presentation will provide a grounding in what eSource is, how it can be deployed, the overall vendor landscape and how to avoid hurdles in the eSource process.
Stephen Boccardo, SVP Business Development and Commercial Strategy, Quartesian
As SVP Business Development and Commercial Strategy, Stephen handles all aspects of customer business development including capability presentations, bid proposals and relationship management. Stephen combines more than 30 years of life science industry experience and dedicated technology expertise with a record of success on the clinical data management and systems side as well as growing startup organizations through sales and marketing leadership.
Mr. Boccardo joined Quartesian from Clinical Ink where he served as Chief Commercial Officer. In this role, he was responsible for all Clinical Ink global sales and marketing activities to drive market adoption of the company’s industry-leading eSource products and solutions. Prior to that, he was at BioClinica, where he served as Senior Vice President, Global Business Development for the company’s eClinical Solutions Division. Prior to BioClinica, Stephen served as Vice President of Information Services for Bio-Pharm Clinical Services (OmniCare). He began his career as a clinical data programming manager at SmithKline Beecham. Stephen holds a master’s degree in computer science from Villanova University and a bachelor’s degree in mathematics from Ursinus College.Message Presenter
Who Should Attend?
- Clinical Operations
- Clinical Data Managers
- Site Personnel
What You Will Learn
- Clear definition of what eSource is and is not
- Current and future status of eSource adoption
- Current vendor landscape
- Strategies for starting an eSource study
Quartesian was formed in January 2003, headquartered in Princeton, N.J. with the goal of providing “Clinical Data Your Way” to its clients. This is accomplished by providing clinical data services faster, more efficient and cost-effective than ever thought possible. The founding members of Quartesian rely not only on their technical expertise, but on their experience as past clients of clinical service providers. Quartesian prides itself on its flexibility, responsiveness, adherence to client specifications and timelines for all projects conducted anywhere in the world. We have worked for over 125+ pharmaceutical, biotechnology and medical device companies with 100% repeat business and no change orders.
Our business model brings together domestic and off-shore staff with minimum overhead and maximum efficiency within a framework of validated computer systems, regulatory compliance and industry best practices. Our long company history, wide geographic presence, high quality standards, cost effectiveness, faster turnaround time, and therapeutic expertise as well as qualified, experienced and talented employee capabilities enhance our client benefits.